Skip to main content

Table 2 Baseline characteristics of critically ill pH1N1 patients, stratified by AKI

From: Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study

Characteristic

Overall

AKI

No AKI

P value

(n = 562)

(n = 342)

(n = 220)

Age (yr)

48.0 (15.0)

49.1 (15.1)

46.4 (14.8)

0.03

Female sex

300 (53.4)

177 (51.8)

123 (55.9)

0.34

Ethnicity (n=555, 336, 219)

   

0.23

   White/Caucasian

327 (58.9)

204 (60.7)

123 (56.2)

 

   Unknown/Mixed/Other

117 (21.1)

68 (20.2)

49 (22.4)

 

   Aboriginal

74 (13.3)

47 (14.0)

27 (12.3)

 

   Asian

37 (6.7)

17 (5.1)

20 (9.1)

 

Any co-morbidity

513 (91.3)

316 (92.4)

197 (89.6)

0.24

   Obesity

150 (26.7)

118 (34.5)

32 (14.6)

<0.0001

   Diabetes mellitus

146 (26.0)

107 (31.3)

39 (17.7)

0.0003

   Chronic obstructive pulmonary disease

98 (17.4)

56 (16.4)

42 (19.1)

0.41

   Alcohol abuse

74 (13.2)

41 (12.0)

33 (15.0)

0.30

   Chronic kidney disease

48 (8.5)

44 (12.9)

4 (1.8)

<0.0001

H1N1 status

   Confirmed

479 (85.2)

291 (85.1)

188 (85.5)

0.90

   Probable

83 (14.8)

51 (14.9)

32 (14.6)

Days of symptoms pre-hospital (n = 532, 326, 206)

4.0 (2.0-7.0)

4.0 (2.0-7.0)

4.0 (2.0-7.0)

0.67

Days of symptoms pre-ICU (n = 549, 336, 213)

5.0 (3.0-8.0)

5.0 (3.0-8.0)

5.0 (3.0-8.0)

0.66

  1. AKI is defined by the RIFLE Injury or Failure categories and no AKI by the RIFLE None or Risk categories.
  2. Categorical data are presented as n (%) and continuous data as mean (SD) or median (Q1-Q3). For each variable, we specify (n) with data if it differs from the total in the first row.